Prothena Corporation plc - stock earnings
PRTA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | -72.2 million USD | 50000 USD |
| 2023Q4 | -67.5 million USD | 316000 USD |
| 2023Q3 | 21.9 million USD | 84.9 million USD |
| 2023Q2 | -54.6 million USD | 4.0 million USD |
| 2023Q1 | -46.9 million USD | 2.2 million USD |
| 2022Q4 | 6.3 million USD | 49.9 million USD |
| 2022Q3 | -45.8 million USD | 1.5 million USD |
| 2022Q2 | -41.2 million USD | 1.3 million USD |
| 2022Q1 | -36.3 million USD | 1.2 million USD |
| 2021Q4 | -33.2 million USD | 1.2 million USD |
| 2021Q3 | 109.2 million USD | 139.2 million USD |
| 2021Q2 | 27.6 million USD | 60.1 million USD |
| 2021Q1 | -36.7 million USD | 160000 USD |
| 2020Q4 | -30.7 million USD | 360000 USD |
| 2020Q3 | -30.6 million USD | 157000 USD |
| 2020Q2 | -26.3 million USD | 195000 USD |
| 2020Q1 | -23.6 million USD | 141000 USD |
| 2019Q4 | -21.6 million USD | 256000 USD |
| 2019Q3 | -19.4 million USD | 205000 USD |
| 2019Q2 | -15.8 million USD | 167000 USD |
| 2019Q1 | -20.9 million USD | 186000 USD |
| 2018Q4 | -22.5 million USD | 194000 USD |
| 2018Q3 | -24.6 million USD | 255000 USD |
| 2018Q2 | -59.9 million USD | 279000 USD |
| 2018Q1 | -48.7 million USD | 227000 USD |
| 2017Q4 | -47.8 million USD | 229000 USD |
| 2017Q3 | -52.4 million USD | 219000 USD |
| 2017Q2 | -17.7 million USD | 26.8 million USD |
| 2017Q1 | -35.4 million USD | 259000 USD |
| 2016Q4 | -48.9 million USD | 171000 USD |
| 2016Q3 | -43.2 million USD | 286000 USD |
| 2016Q2 | -40.4 million USD | 333000 USD |
| 2016Q1 | -27.5 million USD | 265000 USD |
| 2015Q4 | -24.2 million USD | 307000 USD |
| 2015Q3 | -23.0 million USD | 429000 USD |
| 2015Q2 | -18.3 million USD | 278000 USD |
| 2015Q1 | -15.2 million USD | 593000 USD |
| 2014Q4 | -13.1 million USD | 2.0 million USD |
| 2014Q3 | -13.2 million USD | 1.5 million USD |
| 2014Q2 | 1.3 million USD | 15.1 million USD |
| 2014Q1 | 17.9 million USD | 32.2 million USD |
| 2013Q4 | -11.1 million USD | 167000 USD |
| 2013Q3 | -9.7 million USD | 171000 USD |
| 2013Q2 | -11.3 million USD | 167000 USD |
| 2013Q1 | -9.0 million USD | 171000 USD |
| 2012Q4 | -12.2 million USD | 575000 USD |
| 2012Q3 | -8.7 million USD | 944000 USD |
| 2012Q2 | -9.7 million USD | 735000 USD |
| 2012Q1 | -10.8 million USD | 404000 USD |
| 2011Q4 | ? USD | 500000 USD |
| 2010Q4 | ? USD | 1.2 million USD |
PRTA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -147.0 million USD | 91.4 million USD |
| 2022 | -116.9 million USD | 53.9 million USD |
| 2021 | 67.0 million USD | 200.6 million USD |
| 2020 | -111.1 million USD | 853000 USD |
| 2019 | -77.7 million USD | 814000 USD |
| 2018 | -155.6 million USD | 955000 USD |
| 2017 | -153.2 million USD | 27.5 million USD |
| 2016 | -160.1 million USD | 1.1 million USD |
| 2015 | -80.6 million USD | 1.6 million USD |
| 2014 | -7.2 million USD | 50.9 million USD |
| 2013 | -41.0 million USD | 676000 USD |
| 2012 | -41.4 million USD | 2.7 million USD |
| 2011 | -29.7 million USD | 507000 USD |
| 2010 | -12.5 million USD | 1.2 million USD |
PRTA
Price: $20.81
52 week price:
Earnings Per Share: -2.76 USD
P/E Ratio: -21.18
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 314000
Ebitda: -47.3 millionMarket Capitalization: 1.1 billion